0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Parasitic Diseases Therapeutic Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-36N14048
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Parasitic Diseases Therapeutic Market Research Report 2023
BUY CHAPTERS

Global Parasitic Diseases Therapeutic Market Insights, Forecast to 2030

Code: QYRE-Auto-36N14048
Report
December 2024
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Parasitic Diseases Therapeutic Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Parasitic Diseases Therapeutic Market

Parasitic Diseases Therapeutic Market

Parasitic diseases include amebiasis, trichomoniasis, trypanosomiasis, giardiasis, African sleeping sickness, leishmaniasis, and malaria.
Market Analysis and Insights: Global Parasitic Diseases Therapeutic Market
The global Parasitic Diseases Therapeutic market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Parasitic Diseases Therapeutic market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Parasitic Diseases Therapeutic, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Parasitic Diseases Therapeutic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Parasitic Diseases Therapeutic revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Parasitic Diseases Therapeutic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Parasitic Diseases Therapeutic revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Parasitic Diseases Therapeutic Market Report

Report Metric Details
Report Name Parasitic Diseases Therapeutic Market
CAGR 5%
Segment by Type
Segment by Application
  • Commercial
  • Household
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bayer, F. Hoffmann-La Roche, GlaxoSmithKline, Pfizer, Sanaria
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Parasitic Diseases Therapeutic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Parasitic Diseases Therapeutic companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Parasitic Diseases Therapeutic revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Parasitic Diseases Therapeutic Market report?

Ans: The main players in the Parasitic Diseases Therapeutic Market are Bayer, F. Hoffmann-La Roche, GlaxoSmithKline, Pfizer, Sanaria

What are the Application segmentation covered in the Parasitic Diseases Therapeutic Market report?

Ans: The Applications covered in the Parasitic Diseases Therapeutic Market report are Commercial, Household

What are the Type segmentation covered in the Parasitic Diseases Therapeutic Market report?

Ans: The Types covered in the Parasitic Diseases Therapeutic Market report are Peptides Medicine, Insect Repellent, Acaricide, Other

Recommended Reports

Infectious Disease Drugs

Rare Disease Therapeutics

Chronic & Autoimmune Disease

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parasitic Diseases Therapeutic Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Peptides Medicine
1.2.3 Insect Repellent
1.2.4 Acaricide
1.2.5 Other
1.3 Market by Application
1.3.1 Global Parasitic Diseases Therapeutic Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Commercial
1.3.3 Household
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Parasitic Diseases Therapeutic Market Perspective (2019-2030)
2.2 Global Parasitic Diseases Therapeutic Growth Trends by Region
2.2.1 Parasitic Diseases Therapeutic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Parasitic Diseases Therapeutic Historic Market Size by Region (2019-2024)
2.2.3 Parasitic Diseases Therapeutic Forecasted Market Size by Region (2025-2030)
2.3 Parasitic Diseases Therapeutic Market Dynamics
2.3.1 Parasitic Diseases Therapeutic Industry Trends
2.3.2 Parasitic Diseases Therapeutic Market Drivers
2.3.3 Parasitic Diseases Therapeutic Market Challenges
2.3.4 Parasitic Diseases Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Parasitic Diseases Therapeutic by Players
3.1.1 Global Parasitic Diseases Therapeutic Revenue by Players (2019-2024)
3.1.2 Global Parasitic Diseases Therapeutic Revenue Market Share by Players (2019-2024)
3.2 Global Parasitic Diseases Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Parasitic Diseases Therapeutic, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Parasitic Diseases Therapeutic Market Concentration Ratio
3.4.1 Global Parasitic Diseases Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parasitic Diseases Therapeutic Revenue in 2023
3.5 Global Key Players of Parasitic Diseases Therapeutic Head office and Area Served
3.6 Global Key Players of Parasitic Diseases Therapeutic, Product and Application
3.7 Global Key Players of Parasitic Diseases Therapeutic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Parasitic Diseases Therapeutic Breakdown Data by Type
4.1 Global Parasitic Diseases Therapeutic Historic Market Size by Type (2019-2024)
4.2 Global Parasitic Diseases Therapeutic Forecasted Market Size by Type (2025-2030)
5 Parasitic Diseases Therapeutic Breakdown Data by Application
5.1 Global Parasitic Diseases Therapeutic Historic Market Size by Application (2019-2024)
5.2 Global Parasitic Diseases Therapeutic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Parasitic Diseases Therapeutic Market Size (2019-2030)
6.2 North America Parasitic Diseases Therapeutic Market Size by Type
6.2.1 North America Parasitic Diseases Therapeutic Market Size by Type (2019-2024)
6.2.2 North America Parasitic Diseases Therapeutic Market Size by Type (2025-2030)
6.2.3 North America Parasitic Diseases Therapeutic Market Share by Type (2019-2030)
6.3 North America Parasitic Diseases Therapeutic Market Size by Application
6.3.1 North America Parasitic Diseases Therapeutic Market Size by Application (2019-2024)
6.3.2 North America Parasitic Diseases Therapeutic Market Size by Application (2025-2030)
6.3.3 North America Parasitic Diseases Therapeutic Market Share by Application (2019-2030)
6.4 North America Parasitic Diseases Therapeutic Market Size by Country
6.4.1 North America Parasitic Diseases Therapeutic Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Parasitic Diseases Therapeutic Market Size by Country (2019-2024)
6.4.3 North America Parasitic Diseases Therapeutic Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Parasitic Diseases Therapeutic Market Size (2019-2030)
7.2 Europe Parasitic Diseases Therapeutic Market Size by Type
7.2.1 Europe Parasitic Diseases Therapeutic Market Size by Type (2019-2024)
7.2.2 Europe Parasitic Diseases Therapeutic Market Size by Type (2025-2030)
7.2.3 Europe Parasitic Diseases Therapeutic Market Share by Type (2019-2030)
7.3 Europe Parasitic Diseases Therapeutic Market Size by Application
7.3.1 Europe Parasitic Diseases Therapeutic Market Size by Application (2019-2024)
7.3.2 Europe Parasitic Diseases Therapeutic Market Size by Application (2025-2030)
7.3.3 Europe Parasitic Diseases Therapeutic Market Share by Application (2019-2030)
7.4 Europe Parasitic Diseases Therapeutic Market Size by Country
7.4.1 Europe Parasitic Diseases Therapeutic Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Parasitic Diseases Therapeutic Market Size by Country (2019-2024)
7.4.3 Europe Parasitic Diseases Therapeutic Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Parasitic Diseases Therapeutic Market Size (2019-2030)
8.2 China Parasitic Diseases Therapeutic Market Size by Type
8.2.1 China Parasitic Diseases Therapeutic Market Size by Type (2019-2024)
8.2.2 China Parasitic Diseases Therapeutic Market Size by Type (2025-2030)
8.2.3 China Parasitic Diseases Therapeutic Market Share by Type (2019-2030)
8.3 China Parasitic Diseases Therapeutic Market Size by Application
8.3.1 China Parasitic Diseases Therapeutic Market Size by Application (2019-2024)
8.3.2 China Parasitic Diseases Therapeutic Market Size by Application (2025-2030)
8.3.3 China Parasitic Diseases Therapeutic Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Parasitic Diseases Therapeutic Market Size (2019-2030)
9.2 Asia Parasitic Diseases Therapeutic Market Size by Type
9.2.1 Asia Parasitic Diseases Therapeutic Market Size by Type (2019-2024)
9.2.2 Asia Parasitic Diseases Therapeutic Market Size by Type (2025-2030)
9.2.3 Asia Parasitic Diseases Therapeutic Market Share by Type (2019-2030)
9.3 Asia Parasitic Diseases Therapeutic Market Size by Application
9.3.1 Asia Parasitic Diseases Therapeutic Market Size by Application (2019-2024)
9.3.2 Asia Parasitic Diseases Therapeutic Market Size by Application (2025-2030)
9.3.3 Asia Parasitic Diseases Therapeutic Market Share by Application (2019-2030)
9.4 Asia Parasitic Diseases Therapeutic Market Size by Region
9.4.1 Asia Parasitic Diseases Therapeutic Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Parasitic Diseases Therapeutic Market Size by Region (2019-2024)
9.4.3 Asia Parasitic Diseases Therapeutic Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Parasitic Diseases Therapeutic Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Parasitic Diseases Therapeutic Market Size by Type
10.2.1 Middle East, Africa, and Latin America Parasitic Diseases Therapeutic Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Parasitic Diseases Therapeutic Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Parasitic Diseases Therapeutic Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Parasitic Diseases Therapeutic Market Size by Application
10.3.1 Middle East, Africa, and Latin America Parasitic Diseases Therapeutic Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Parasitic Diseases Therapeutic Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Parasitic Diseases Therapeutic Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Parasitic Diseases Therapeutic Market Size by Country
10.4.1 Middle East, Africa, and Latin America Parasitic Diseases Therapeutic Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Parasitic Diseases Therapeutic Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Parasitic Diseases Therapeutic Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Parasitic Diseases Therapeutic Introduction
11.1.4 Bayer Revenue in Parasitic Diseases Therapeutic Business (2019-2024)
11.1.5 Bayer Recent Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Parasitic Diseases Therapeutic Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Parasitic Diseases Therapeutic Business (2019-2024)
11.2.5 F. Hoffmann-La Roche Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Parasitic Diseases Therapeutic Introduction
11.3.4 GlaxoSmithKline Revenue in Parasitic Diseases Therapeutic Business (2019-2024)
11.3.5 GlaxoSmithKline Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Parasitic Diseases Therapeutic Introduction
11.4.4 Pfizer Revenue in Parasitic Diseases Therapeutic Business (2019-2024)
11.4.5 Pfizer Recent Developments
11.5 Sanaria
11.5.1 Sanaria Company Details
11.5.2 Sanaria Business Overview
11.5.3 Sanaria Parasitic Diseases Therapeutic Introduction
11.5.4 Sanaria Revenue in Parasitic Diseases Therapeutic Business (2019-2024)
11.5.5 Sanaria Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Parasitic Diseases Therapeutic Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Peptides Medicine
    Table 3. Key Players of Insect Repellent
    Table 4. Key Players of Acaricide
    Table 5. Key Players of Other
    Table 6. Global Parasitic Diseases Therapeutic Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Parasitic Diseases Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Parasitic Diseases Therapeutic Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Parasitic Diseases Therapeutic Market Share by Region (2019-2024)
    Table 10. Global Parasitic Diseases Therapeutic Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Parasitic Diseases Therapeutic Market Share by Region (2025-2030)
    Table 12. Parasitic Diseases Therapeutic Market Trends
    Table 13. Parasitic Diseases Therapeutic Market Drivers
    Table 14. Parasitic Diseases Therapeutic Market Challenges
    Table 15. Parasitic Diseases Therapeutic Market Restraints
    Table 16. Global Parasitic Diseases Therapeutic Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Parasitic Diseases Therapeutic Revenue Share by Players (2019-2024)
    Table 18. Global Top Parasitic Diseases Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parasitic Diseases Therapeutic as of 2023)
    Table 19. Global Parasitic Diseases Therapeutic Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Parasitic Diseases Therapeutic Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Parasitic Diseases Therapeutic, Headquarters and Area Served
    Table 22. Global Key Players of Parasitic Diseases Therapeutic, Product and Application
    Table 23. Global Key Players of Parasitic Diseases Therapeutic, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Parasitic Diseases Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Parasitic Diseases Therapeutic Revenue Market Share by Type (2019-2024)
    Table 27. Global Parasitic Diseases Therapeutic Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Parasitic Diseases Therapeutic Revenue Market Share by Type (2025-2030)
    Table 29. Global Parasitic Diseases Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Parasitic Diseases Therapeutic Revenue Share by Application (2019-2024)
    Table 31. Global Parasitic Diseases Therapeutic Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Parasitic Diseases Therapeutic Revenue Share by Application (2025-2030)
    Table 33. North America Parasitic Diseases Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Parasitic Diseases Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Parasitic Diseases Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Parasitic Diseases Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Parasitic Diseases Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Parasitic Diseases Therapeutic Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Parasitic Diseases Therapeutic Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Parasitic Diseases Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Parasitic Diseases Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Parasitic Diseases Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Parasitic Diseases Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Parasitic Diseases Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Parasitic Diseases Therapeutic Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Parasitic Diseases Therapeutic Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Parasitic Diseases Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Parasitic Diseases Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Parasitic Diseases Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Parasitic Diseases Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Parasitic Diseases Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Parasitic Diseases Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Parasitic Diseases Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Parasitic Diseases Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Parasitic Diseases Therapeutic Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Parasitic Diseases Therapeutic Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Parasitic Diseases Therapeutic Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Parasitic Diseases Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Parasitic Diseases Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Parasitic Diseases Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Parasitic Diseases Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Parasitic Diseases Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Parasitic Diseases Therapeutic Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Parasitic Diseases Therapeutic Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Bayer Company Details
    Table 66. Bayer Business Overview
    Table 67. Bayer Parasitic Diseases Therapeutic Product
    Table 68. Bayer Revenue in Parasitic Diseases Therapeutic Business (2019-2024) & (US$ Million)
    Table 69. Bayer Recent Developments
    Table 70. F. Hoffmann-La Roche Company Details
    Table 71. F. Hoffmann-La Roche Business Overview
    Table 72. F. Hoffmann-La Roche Parasitic Diseases Therapeutic Product
    Table 73. F. Hoffmann-La Roche Revenue in Parasitic Diseases Therapeutic Business (2019-2024) & (US$ Million)
    Table 74. F. Hoffmann-La Roche Recent Developments
    Table 75. GlaxoSmithKline Company Details
    Table 76. GlaxoSmithKline Business Overview
    Table 77. GlaxoSmithKline Parasitic Diseases Therapeutic Product
    Table 78. GlaxoSmithKline Revenue in Parasitic Diseases Therapeutic Business (2019-2024) & (US$ Million)
    Table 79. GlaxoSmithKline Recent Developments
    Table 80. Pfizer Company Details
    Table 81. Pfizer Business Overview
    Table 82. Pfizer Parasitic Diseases Therapeutic Product
    Table 83. Pfizer Revenue in Parasitic Diseases Therapeutic Business (2019-2024) & (US$ Million)
    Table 84. Pfizer Recent Developments
    Table 85. Sanaria Company Details
    Table 86. Sanaria Business Overview
    Table 87. Sanaria Parasitic Diseases Therapeutic Product
    Table 88. Sanaria Revenue in Parasitic Diseases Therapeutic Business (2019-2024) & (US$ Million)
    Table 89. Sanaria Recent Developments
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Parasitic Diseases Therapeutic Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Parasitic Diseases Therapeutic Market Share by Type: 2023 VS 2030
    Figure 3. Peptides Medicine Features
    Figure 4. Insect Repellent Features
    Figure 5. Acaricide Features
    Figure 6. Other Features
    Figure 7. Global Parasitic Diseases Therapeutic Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Parasitic Diseases Therapeutic Market Share by Application: 2023 VS 2030
    Figure 9. Commercial Case Studies
    Figure 10. Household Case Studies
    Figure 11. Parasitic Diseases Therapeutic Report Years Considered
    Figure 12. Global Parasitic Diseases Therapeutic Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Parasitic Diseases Therapeutic Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Parasitic Diseases Therapeutic Market Share by Region: 2023 VS 2030
    Figure 15. Global Parasitic Diseases Therapeutic Market Share by Players in 2023
    Figure 16. Global Top Parasitic Diseases Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parasitic Diseases Therapeutic as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Parasitic Diseases Therapeutic Revenue in 2023
    Figure 18. North America Parasitic Diseases Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Parasitic Diseases Therapeutic Market Share by Type (2019-2030)
    Figure 20. North America Parasitic Diseases Therapeutic Market Share by Application (2019-2030)
    Figure 21. North America Parasitic Diseases Therapeutic Market Share by Country (2019-2030)
    Figure 22. United States Parasitic Diseases Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Parasitic Diseases Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Parasitic Diseases Therapeutic Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Parasitic Diseases Therapeutic Market Share by Type (2019-2030)
    Figure 26. Europe Parasitic Diseases Therapeutic Market Share by Application (2019-2030)
    Figure 27. Europe Parasitic Diseases Therapeutic Market Share by Country (2019-2030)
    Figure 28. Germany Parasitic Diseases Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Parasitic Diseases Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Parasitic Diseases Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Parasitic Diseases Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Parasitic Diseases Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Parasitic Diseases Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Parasitic Diseases Therapeutic Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Parasitic Diseases Therapeutic Market Share by Type (2019-2030)
    Figure 36. China Parasitic Diseases Therapeutic Market Share by Application (2019-2030)
    Figure 37. Asia Parasitic Diseases Therapeutic Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Parasitic Diseases Therapeutic Market Share by Type (2019-2030)
    Figure 39. Asia Parasitic Diseases Therapeutic Market Share by Application (2019-2030)
    Figure 40. Asia Parasitic Diseases Therapeutic Market Share by Region (2019-2030)
    Figure 41. Japan Parasitic Diseases Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Parasitic Diseases Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Parasitic Diseases Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Parasitic Diseases Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Parasitic Diseases Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Parasitic Diseases Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Parasitic Diseases Therapeutic Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Parasitic Diseases Therapeutic Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Parasitic Diseases Therapeutic Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Parasitic Diseases Therapeutic Market Share by Country (2019-2030)
    Figure 51. Brazil Parasitic Diseases Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Parasitic Diseases Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Parasitic Diseases Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Parasitic Diseases Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Parasitic Diseases Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Parasitic Diseases Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Bayer Revenue Growth Rate in Parasitic Diseases Therapeutic Business (2019-2024)
    Figure 58. F. Hoffmann-La Roche Revenue Growth Rate in Parasitic Diseases Therapeutic Business (2019-2024)
    Figure 59. GlaxoSmithKline Revenue Growth Rate in Parasitic Diseases Therapeutic Business (2019-2024)
    Figure 60. Pfizer Revenue Growth Rate in Parasitic Diseases Therapeutic Business (2019-2024)
    Figure 61. Sanaria Revenue Growth Rate in Parasitic Diseases Therapeutic Business (2019-2024)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart